BiomX Inc. (PHGE) Tops Q2 EPS by 16c

Go back to BiomX Inc. (PHGE) Tops Q2 EPS by 16c

H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)

August 16, 2024 2:58 PM EDT

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $2.00 price target on BiomX (NYSE: PHGE).

The analyst comments "Valuation and risks to price target achievement. We reiterate our Buy rating and $2 price target. Our valuation is based on our clinical net present... More